NeueHealth, Inc.
NEUE
$6.49
$0.091.41%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 98.82% | 90.94% | 48.04% | 90.91% | 65.65% |
| Total Depreciation and Amortization | -63.58% | -15.01% | -14.82% | -16.81% | -60.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.85% | -90.21% | -3.98% | -104.42% | -125.73% |
| Change in Net Operating Assets | 113.08% | 98.93% | 80.67% | 92.69% | -112.68% |
| Cash from Operations | 92.64% | 98.70% | 73.92% | 92.08% | -369.99% |
| Capital Expenditure | -191.88% | -186.64% | -53.11% | 96.56% | 95.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 148.29% | 14,216.06% | -- |
| Other Investing Activities | 93.95% | -99.94% | 98.24% | -99.66% | -164.99% |
| Cash from Investing | 90.95% | -100.01% | 98.28% | -71.11% | -177.21% |
| Total Debt Issued | 385.80% | -120.56% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,153.15% | 24.82% | 9.56% | -4.38% | -228.96% |
| Cash from Financing | -260.41% | -128.98% | 1,675.49% | -15,172.73% | -94.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.22% | 94.50% | 101.87% | -279.89% | -206.54% |